Trans-sialidase-based vaccine candidate protects against <i>Trypanosoma cruzi</i> infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype.
作者:
DOI
10.18632/oncotarget.18217
PMID
28938533
发布时间
2018-11-13
- 浏览12

Oncotarget
58003-58020页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文